
Nordson (NDSN) Stock Forecast & Price Target
Nordson (NDSN) Analyst Ratings
Bulls say
Nordson is a solid investment with strong long-term potential, boasting a stable balance sheet and a BUY rating, with a price target of $375. Their recent performance has been impressive, and they are well-positioned for growth in the medical and test & inspection industries. However, investors should be aware of potential volatility in earnings due to the company's short-cycle businesses and limited visibility, while also considering challenges such as currency fluctuations and the ongoing COVID-19 pandemic. Nevertheless, NDSN's strong backlog and strategic initiatives, including M&A and organic investments, make it a promising investment opportunity.
Bears say
Nordson is expected to experience a strong organic sales growth of 9% in their fiscal 2026, driven by their Advanced Technology Solutions segment. However, with the recent divestiture of their medical contract and contribution from the CapstanAG Systems, their revenue growth may be slightly hindered. Despite this, Nordson is well-positioned in the market and has a strong track record of generating high returns and cash flow, making it a high-quality company with a favorable secular positioning. However, with ATS orders starting to show positive momentum, the market has become overly negative on the company, providing a good entry point for investors.
This aggregate rating is based on analysts' research of Nordson and is not a guaranteed prediction by Public.com or investment advice.
Nordson (NDSN) Analyst Forecast & Price Prediction
Start investing in Nordson (NDSN)
Order type
Buy in
Order amount
Est. shares
0 shares